Evidence map›Paper›PMID 40933099›Full record

ReviewJournal of the Society for Cardiovascular Angiography & Interventions2025

Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.

Philippe Généreux, Marko Banovic, Duk-Hyun Kang, Gennaro Giustino, Bernard D Prendergast, Brian R Lindman, David E Newby, Philippe Pibarot, Björn Redfors, Allan Schwartz and 3 more

Abstract readReview
In one paragraph

Review in Journal of the Society for Cardiovascular Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: A New Management Paradigm?Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Philippe GénéreuxGagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey.
Marko BanovicBelgrade Medical School, University of Belgrade, Serbia.
Duk-Hyun KangAsan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Gennaro GiustinoGagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey.
Bernard D PrendergastDepartment of Cardiology, Guys and St Thomas' NHS Foundation Trust Hospital London, London, United Kingdom.
Brian R LindmanStructural Heart and Valve Center, Vanderbilt University Medical Center, Nashville, Tennessee.
David E NewbyBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Philippe PibarotQuebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Björn RedforsDepartment of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University, Gothenburg, Sweden.
Allan SchwartzNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
Roxanna SeyedinEdwards Lifesciences, Irvine, California.
Bernard IungBichat Hospital, APHP, and INSERM LVTS 1148, Université Paris-Cité, Paris, France.
Marc R DweckBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Current guidelines recommend a strategy of clinical surveillance (CS) for patients with asymptomatic severe aortic stenosis and normal left ventricular ejection fraction. Methods: PubMed, Embase, and ClinicalTrials.gov were searched through November 2024 for randomized controlled trials (RCTs) and observational studies comparing surgical aortic valve replacement or transcatheter aortic valve replacement with CS in patients with asymptomatic severe aortic stenosis. Results: Sixteen eligible studies (12 observational studies and 4 RCTs) were identified, with a total of 3919 patients in the observational studies and 1427 patients in the RCTs. In the pooled analyses combining observational studies and RCTs, aortic valve replacement (AVR) was associated with significantly reduced all-cause mortality (incidence rate ratio [IRR], 0.42; 95% CI, 0.31-0.58; Conclusions: Data from observational studies and recent RCTs suggest that a strategy of preemptive AVR is associated with improved survival and lower rates of unplanned cardiovascular or HF-related hospitalizations and stroke compared to CS.

Indexed as

aortic stenosisaortic valve replacementmeta-analysissystematic reviewtranscatheter aortic valve replacement

Identifiers

PMID40933099
PMCPMC12418467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.